Sanofi Pasteur’s New Quadrivalent Influenza Vaccine Accepted for Review for European Approval

Sanofi Pasteur’s New Quadrivalent Influenza Vaccine Accepted for Review for European Approval

[at noodls] – PRESS RELEASE Sanofi Pasteur’s New Quadrivalent Influenza Vaccine Accepted for Review for European Approval – The addition of a fourth influenza virus strain to the seasonal trivalent vaccine aims to increase … more

View todays social media effects on SNY

View the latest stocks trending across Twitter. Click to view dashboard

See who Sanofi is hiring next, click here to view

Share this post